Kathleen A. Fairman

Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization

Brenda R. Motheral, Kathleen A. Fairman · Medical Care · 2001 · 164 citations

Pharmacy, Pharmacoeconomics, Pharmacy Practice +17

Evaluating Medication Adherence: Which Measure Is Right for Your Program?

Kathleen A. Fairman, Brenda Matheral · Journal of Managed Care Pharmacy · 2000 · 113 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacy Practice +15

Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race

Kathleen A. Fairman, Alyssa M. Peckham, David A. Sclar · Journal of Attention Disorders · 2017 · 106 citations

Medicine, Pharmacotherapy, Psychiatry +17

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Alyssa M. Peckham, Kathleen A. Fairman, David A. Sclar · Drug Safety · 2017 · 90 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs

Kathleen A. Fairman, Brenda R. Motheral, Rochelle Henderson · Clinical Therapeutics · 2003 · 70 citations

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +16